perylene has been researched along with Cancer of the Thyroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Javidi, MA; Mehrparvar, B; Mohammadian, A; Piryaei, M; Shahriari, F | 1 |
| Ahn, JC; Hwang, CW; Jin, JO; Kang, HW; Kim, H; Kim, SW; Seok, KH | 1 |
2 other study(ies) available for perylene and Cancer of the Thyroid
| Article | Year |
|---|---|
Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Fibroblasts; Humans; Inhibitory Concentration 50; Neoplasm Metastasis; Perylene; Signal Transduction; Thyroid Neoplasms | 2021 |
Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Topics: Animals; Anthracenes; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Mice; Mitophagy; Perylene; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2018 |